Bafna Pharmaceuticals Limited specializes in Pharmaceuticals within the Healthcare sector.
Bafna Pharmaceuticals Limited, with Security Code 532989, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2023-10-01 | 2023-12-31 | 284.42 | -29.42 | 294.21 | -1.24 | -26.96 | 9.79 | -12.71 | -29.42 |
| 2023-07-01 | 2023-09-30 | 406.78 | 24.84 | 408.37 | 1.05 | -30.32 | 1.59 | -12.41 | 24.84 |
| 2023-04-01 | 2023-06-30 | 419.47 | 63.51 | 438.16 | 2.68 | -47.96 | 18.69 | -12.13 | 63.51 |
| 2023-01-01 | 2023-03-31 | 422.44 | 53.72 | 425.02 | 2.34 | -22.09 | 2.59 | -15.25 | 56.50 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 28% |
| 3 Years: | 29% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 19% |
| 3 Years: | 8% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 74% |
| 3 Years: | -16% |
| 1 Year: | -18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -15% |
| 3 Years: | -13% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| TTM: | 90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 74% |
| 3 Years: | -16% |
| 1 Year: | -18% |
